Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangbingdu Koufuye for adults with influenza or common cold
ChiCTR-TRC-12002399Phase 4Completed
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xiangxue Antiviral Oral Liquid in influenza and nasopharyngitis (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoints: Rate of improvement of symptoms, Time of fever clearance and 2 more. Started Apr 2011; status: completed.
02
Drugs
Xiangxue Antiviral Oral Liquid
03
Conditions
influenzanasopharyngitis
Beyond the preview
Go deeper on ChiCTR-TRC-12002399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002399.